29 results
S-4/A
CHRS
Coherus Biosciences Inc
24 Jul 23
Registration of securities issued in business combination transactions (amended)
4:42pm
of this proxy statement/prospectus to the date of the Surface special meeting, and through the date the First Merger is consummated. Given that the price per … is traded on the Nasdaq Capital Market (“Nasdaq CM”) under the symbol “SURF.”
Surface will hold a special meeting of its stockholders to consider
DRS
EX-3.3
CHRS
Coherus Biosciences Inc
4 Aug 14
Draft registration statement
12:00am
RECORDS
ARTICLE II. STOCKHOLDERS
Section 1.
ANNUAL MEETING
Section 2.
SPECIAL MEETING
Section 3.
PLACE OF STOCKHOLDER MEETINGS
Section 4.
NOTICE … provided inSection 1 of Article III of these Bylaws.
Section 2. SPECIAL MEETING. A special meeting of the stockholders may be called by the President
S-4/A
EX-99.2
CHRS
Coherus Biosciences Inc
24 Jul 23
Registration of securities issued in business combination transactions (amended)
4:42pm
in connection with the Mergers. 3. To approve the adjournment or postponement of the Surface special meeting to solicit additional proxies … if there are not sufficient votes cast at the Surface special meeting to approve the Surface merger proposal or to ensure that any supplemental or amended disclosure
424B3
CHRS
Coherus Biosciences Inc
26 Jul 23
Prospectus supplement
4:59pm
of this proxy statement/prospectus to the date of the Surface special meeting, and through the date the First Merger is consummated. Given that the price per … is traded on the Nasdaq Capital Market (“Nasdaq CM”) under the symbol “SURF.”
Surface will hold a special meeting of its stockholders to consider and vote
S-4
2yosf gy2
7 Jul 23
Registration of securities issued in business combination transactions
5:03pm
8-K
EX-3.1
r1olyb 9gtqguelfflm
18 Nov 20
Departure of Directors or Certain Officers
4:06pm
8-K
EX-99.1
j2m1nyt9dq rd
2 Aug 23
Coherus BioSciences Reports Second Quarter 2023 Financial Results and Business Highlights
4:05pm
8-K
EX-2.1
mgoi i6i3902a7o
16 Jun 23
Coherus to Acquire Surface Oncology
7:06am
425
zs52hbvogzhnevy6pfvb
16 Jun 23
Business combination disclosure
7:09am
425
an6tl
16 Jun 23
Business combination disclosure
8:08am
424B5
3dvxwb
17 Nov 22
Prospectus supplement for primary offering
5:37pm
424B5
bjgwt 5hm9
12 Sep 23
Prospectus supplement for primary offering
6:04am